Targeted Therapies for Advanced Renal Cell Carcinoma: New Standards of Care
The Center for Biomedical Continuing Education
Last Modified: February 13, 2009
Conference Dates: February 26, 2009
Conference Location: Orlando, FL
Sponsoring Group: The Center for Biomedical Continuing Education
Conference Web Page URL:www.thecbce.com/renalcell2009
Topics Covered: renal cell carcinoma, gene mutations, cellular signaling defects, metastasectomy, cytoreductive nephrectomy
- Describe common gene mutations and cellular signaling defects that are characteristics of RCC.
- Describe prognostic and predictive factors that may be useful in determining optimal care for patients with RCC.
- Describe clinical considerations in the use of metastasectomy and cytoreductive nephrectomy followed by systematic therapy for patients with mRCC.
- Describe recent data regarding the safety and efficacy of novel agents targeting cell growth pathways for the treatment of RCC.
- Discuss recent clinical trials investigating the safety and efficacy of targeted agents that impact the vascular and endothelial growth factor-signaling pathway for the treatment of RCC.
Who Should Attend: medical oncologists, radiation oncologists, surgical oncologists, nurses, pharmacists, physicial assistants and other healthcare professionals interested in the treatment and care of patients with RCC
Continuing Education: Yes
ASCO: Anti-PD-1 Antibody Active Against Various Cancers
Jun 5, 2012 - The anti-programmed death-1 monoclonal antibody BMS-936558 is active in patients with melanoma, non-small-cell lung cancer, and renal cell cancer that has progressed despite standard therapy, according to a study published online June 2 in the New England Journal of Medicine to coincide with presentation at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in Chicago.
Frequently Asked Questions
National Cancer Institute
I Wish You Knew
How cancer patients have changed my life
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!